medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2016, Número 6

<< Anterior Siguiente >>

Ann Hepatol 2016; 15 (6)


Pedunculated hepatic focal nodular hyperplasia

Zeina Abdel-Rauf, Glick Y

Idioma: Ingles.
Referencias bibliográficas: 10
Paginas: 929-931
Archivo PDF: 389.80 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fukukura Y, Nakashima O, Kusaba A, Kage M, Kojiro M. Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. J Hepatol 1998; 29: 470-5.

  2. Craig J, Peters R, Edmundson H. Tumors of the liver and intrahepatic bile ducts. Fasc. 26, 2nd Ed. DC Armed Forces Institute of Pathology, Washington, DC 1989. p. 6.

  3. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5:94.

  4. Fowler KJ, Brown JJ, Narra VR. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis. Hepatology 2011; 54: 2227-37.

  5. van Kessel CS, de Boer E, ten Kate FJ, Brosens LA, Veldhuis WB, van Leeuwen MS. Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic acid contrast-enhanced MRI. Abdom Imaging 2013; 38: 490-501.

  6. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 201: 520-9.

  7. McInnes MDF, Hibbert RM, Inácio JR, Schieda N. Focal nodular hyperplasia and Hepatocellular adenoma: Accuracy of gadoxetic acid-enhanced MR imaging – a systematic review. Radiology 2015; 277: 413-23.

  8. Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey J-N. MD5SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 2013; 17: 636-44.

  9. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Meignan M, Fagniez PL, Zafrani ES, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674-81.

  10. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, Blumgart LH. Management of 155 patients with benign liver tumours. Br J Surg 2001; 88: 808-13.




2020     |     www.medigraphic.com